LYMPHOMA, LARGE B-CELL, DIFFUSE
Clinical trials for LYMPHOMA, LARGE B-CELL, DIFFUSE explained in plain language.
Never miss a new study
Get alerted when new LYMPHOMA, LARGE B-CELL, DIFFUSE trials appear
Sign up with your email to follow new studies for LYMPHOMA, LARGE B-CELL, DIFFUSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise for hard-to-treat blood cancers
Disease control CompletedThis study tested an oral drug called LOXO-305 in 87 Chinese adults with lymphoma or chronic lymphocytic leukemia who had already received standard treatments. The goal was to see how safe and effective the drug is. Participation could last up to four years. The study is now comp…
Matched conditions: LYMPHOMA, LARGE B-CELL, DIFFUSE
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 17, 2026 06:50 UTC
-
Less chemo, same control: new hope for HIV lymphoma patients
Disease control CompletedThis study tested a shorter course of a chemotherapy combination called EPOCH-R in 68 people with HIV and a type of lymphoma. The goal was to see if stopping treatment early, once the cancer was gone, could reduce side effects and still keep the lymphoma under control. Results sh…
Matched conditions: LYMPHOMA, LARGE B-CELL, DIFFUSE
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New vaccine strategy aims to shield lymphoma patients from deadly pneumonia
Prevention CompletedThis study tested a two-step pneumococcal vaccine in 26 people with diffuse large B-cell lymphoma who were receiving rituximab chemotherapy. The goal was to see if giving two different pneumonia vaccines in sequence could boost protection against serious infections. Researchers m…
Matched conditions: LYMPHOMA, LARGE B-CELL, DIFFUSE
Phase: PHASE3 • Sponsor: University Hospital, Tours • Aim: Prevention
Last updated May 06, 2026 16:01 UTC
-
HIV Patients' CAR T-Cell outcomes under the microscope
Knowledge-focused CompletedThis study looked back at 30 people with HIV who had already received CAR T-cell therapy for certain blood cancers. Researchers collected standard medical data to see what side effects occurred and how the immune system changed over time. The goal was to learn more about safety a…
Matched conditions: LYMPHOMA, LARGE B-CELL, DIFFUSE
Sponsor: AIDS Malignancy Consortium • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC